16:33 EDT Prelude Therapeutics files $400M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRLD:
- Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
- Prelude Therapeutics’ Legal Peril: Navigating Corruption Risks in China and Taiwan
- Prelude Therapeutics sees cash runway into 2026
- Prelude Therapeutics reports Q1 EPS (42c), consensus (48c)
- Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update